The Size of the Asia Pacific Dental Bone Graft Substitutes Market was valued at USD 121.90 Million in 2023 and is poised to reach USD 198.11 Million by 2028, with a CAGR of 10.2% during the predicted period 2023 to 2028.
The growing prevalence of dental disorders and the rising demand for medical and dental tourism are the main drivers driving the market's rise. In addition, the market is expanding due to the increase in the development of technological advancements and an increase in the public awareness of preventative care. Furthermore, to preserve the existing jaw, bone grafting is performed before implant insertion, which helps in the successful surgery implant by expanding the use of synthetic and biocompatible grafts, which is also a significant driver and is driving the market growth.
Bone grafts are also used to repair or replace the damage, and they help in the growth of bone surrounding the implant. Also, bone grafting is used before dental implants to replace lost teeth. In dentistry, bone grafts are also utilized as fillers and scaffolds to help bone growth and enhance wound healing. Further, they are biodegradable and do have an antigen-antibody response.
Dental bone grafts also result in the new bone that serves as a mineral reservoir. Due to growing patient awareness and the high frequency of dental diseases, many regional companies will likely enter the dental bone graft substitute market in the following years. Also, an increase in the developments and new enhancements in the technology is driving the demand of the dental bone graft market.
An increase in the high cost of dental procedures with the lack of reimbursement policies creates hurdles in the market's growth. The average price of dental procedures has been increasing all over the world. Due to this, people are hesitant to undergo the guidelines that restrict the development of the market.
This research report on the APAC dental bone graft substitutes market has been segmented and sub-segmented into the following categories:
By Type:
By Application:
By Product:
By Country:
Geographically, the Asia Pacific market holds a significant share in the dental bone graft substitute market, and it is estimated to have exponential growth in the forecasted years. The market growth is due to the increase in the demand for dental and medical tourism due to the rise in the burden of dental disorders in the region due to the constant change in lifestyle and eating habits.
China's dental bone graft substitutes market is also expected to grow in the market share in the upcoming years by raising the number of dental implants with spreading awareness and initiatives into the people. As a result, China is predicted to be the next significant market for dental implants, intimately related to the need for dental bone transplant substitutes and dental barrier membranes.
India's dental bone graft substitutes market is expected to have significant growth in the dental bone grafts substitute market over the projected period by growing consumer awareness and dentist acceptability among people.
Dental implants are also becoming increasingly popular among Japanese patients and dentists. An increase in the competition of the market players is driving the market growth, such as GC Corporation is the market leader in Japan for dental bone graft replacements. HOYA Technological and Geistlich are in second and third place
Furthermore, the Australian dental bone graft substitutes market is expected to enlarge in the forecasted years. The rise in the market share of allografts in the dental biomaterials industry is a continuing trend driving the market growth. And over the projection period, the increase in the demand from dental professionals and the simplification of the regulatory approval procedure will help drive this market.
KEY MARKET PLAYERS
Notable Companies Operating the APAC Dental Bone Graft Substitutes Market Profiled in the Report are Institut Straumann AG (Switzerland), Geistlich (Switzerland) DENTSPLY International (U.S.), Zimmer Biomet (U.S.), Medtronic (Ireland), BioHorizons IPH, Inc. (U.S.), ACE Surgical Supply Company, Inc. (U.S.), RTI Surgical, Inc. (U.S.), LifeNet Health (U.S.), and Dentium (Korea).,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region